Key facts
- It has raised $20.0M; the latest was Early Stage VC ($10.0M) in Jul 2024.
- Notable investors include Hunter Lewis, Imagine H2O, Momentum Capital, PureTerra Ventures, The Biomimicry Institute.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Sudoc
- ·The full record, as it builds
Funding rounds
No funding rounds for Sudoc are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sudoc
Operatot of a chemical company intended to replace toxic chemicals with sustainable use and the well-being of our planet and humankind. The company specializes in a miracle molecule, called taml, which has a range of applications like treating mold, cleaning wastewater, and mineralizing waste pharmaceuticals, enabling people to get a toxin-free chemical option.
- Sector
- Materials and Resources
- HQ
- Pittsburgh, PA, United States
- Founded
- 2020
- Employees
- 24
- Website
- sudoc.com/
- Ownership
- Privately Held (backing)
Sudoc doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sudoc shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sudoc in its N-PORT filings yet. We sweep new filings monthly.